Genesis Pharmaceuticals Limited Pharmaceutical Import Profile — United Kingdom (DGFT 2022–2026)

Name: Genesis Pharmaceuticals Limited Pharmaceutical Import Records from India — 2 Products, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Genesis Pharmaceuticals Limited — Pharmaceutical Importer Profile (2026) | 2 Products, $1.4M Trade | TransData Nexus

Genesis Pharmaceuticals Limited

Pharmaceutical Importer · United Kingdom · Gastrointestinal Focus · $1.4M Total Trade · DGFT Verified

Genesis Pharmaceuticals Limited is a pharmaceutical importer based in United Kingdom with a total trade value of $1.4M across 2 products in 2 therapeutic categories. Based on 54 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Genesis Pharmaceuticals Limited sources from 5 verified Indian suppliers, with Milan Laboratories (india) Private Limited accounting for 30.1% of imports.

Genesis Pharmaceuticals Limited — Import Portfolio & Supplier Network

Genesis Pharmaceuticals Limited import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Genesis Pharmaceuticals Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Milan Laboratories (india) Private Limited	$258.0K	11	30.1%
Ind-swift Limited	$238.6K	6	27.8%
J B Chemicals And Pharmaceuticals Limited

What Formulations Does Genesis Pharmaceuticals Limited Import?

Formulation	Value	Ships
Pharmaceutical goods / harmless medicines tramadol 50MG Each capsule contains tramadol 50 MG (qty. 97258 x 10 x 10c	$104.3K	3
Pharmaceutical goods / harmless medicines tramadol 50MG Each capsule contains tramadol 50 MG (qty. 96619 x 10 x 10c	$103.6K	3
Lorazepam 0.50MG 4x7tabs uk exp	$84.0K	3
Lorazepam 0.50MG tablets - Pack size: 4 x 7's uk	$55.1K	3
Pharmaceutical goods / harmless medicines tramadol 50MG Each capsule contains tramadol 50 MG (qty. 97241 x 10 x 10c)	$50.0K	1
Trazodone hydrocloride 50MG 5ML oral solution 120ML btl batch no as250148a as250149a as250150a mfg dt 04	$50.0K	1
Bisacodyl 5MG Gastro-Resistant tabs12 yrs plusb.no.iq10823 to iq11023 manufacturing .mar-2023exp.feb-202662110x60=3726600	$48.4K	1
Bisacodyl 5MG Gastro-Resistant tabs12 yrs plusb.no.iq11123iq11223 manufacturing .apr-2023exp.mar-202624908x100=2490800	$46.5K	1
Bisacodyl 5MG bisacodyl 5 MG gastro - resistant tablets 12 years plus batchno. iq12623 & iq12723 manufacturing sep.2023	$45.4K	1
Trazodone hydrocloride 50MG/5ML oral solution-120ML/btl batch no. as230282a as230283a manufacturing dt 09/2023 exp dt	$41.1K	1
Promethazine hydrochloride tablets 10mgb.no.xt10123 to xt10623 manufacturing .mar-2023exp.feb-202649075x56=2748200	$35.1K	1
Bisacodyl 5MG Gastro-Resistant tabs12 yrs plusb.no.iq10623iq10723 manufacturing .feb/mar-23exp.jan/feb-2640890x60=2453400	$31.8K	1
Bisacodyl 5MG bisacodyl 5 MG gastro - resistant tablets 12 years plus batchno. iq12323 & iq12523 manufacturing aug.2023	$31.3K	1
Lorazepam 0.50MG tablets - Pack size 4x 7s	$21.3K	1
Lorazepam 0.50MG 4x7tabs uk exp	$18.0K	1

Genesis Pharmaceuticals Limited imports 29 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Bisacodyl	Gastrointestinal	$1.1M	34	7.3%	3
2	Lorazepam	CNS & Psychiatric	$290.1K	20	7.0%	4

Genesis Pharmaceuticals Limited imports 2 pharmaceutical products across 2 categories into United Kingdom totaling $1.4M.

Genesis Pharmaceuticals Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Genesis Pharmaceuticals Limited is a privately held pharmaceutical company based in the United Kingdom, specializing in the wholesale distribution of pharmaceutical goods. (find-and-update.company-information.service.gov.uk) Established on 29 September 1999, the company is headquartered at Scottish Provident House, 3rd Floor, 76 - 80 College Road, Harrow, Middlesex, HA1 1BQ.

The company's primary focus is on the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Genesis Pharmaceuticals Limited plays a significant role in the UK's pharmaceutical supply chain by supplying wholesalers and hospitals nationwide from a centrally located warehouse.

2Distribution Network

Genesis Pharmaceuticals Limited operates a centralized distribution model, supplying wholesalers and hospitals across the United Kingdom from its centrally located warehouse. The company's logistics capabilities are designed to ensure timely delivery of pharmaceutical products, leveraging a responsive and high-quality supply chain.

3Industry Role

In the United Kingdom's pharmaceutical supply chain, Genesis Pharmaceuticals Limited functions as a primary wholesaler. The company imports finished pharmaceutical formulations from various suppliers, including those in India, and distributes these products to wholesalers and hospitals nationwide.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Genesis Pharmaceuticals Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Genesis Pharmaceuticals Limited's sourcing strategy exhibits a notable concentration on a limited number of suppliers. The company's total import value from India amounts to $1.4 million USD, with 54 shipments covering 29 unique formulations. The top five products imported are Bisacodyl ($1.1 million, 7.3% share) and Lorazepam ($290,000, 7.0% share), indicating a high dependency on these specific products.

This concentration suggests a strategic choice to focus on high-demand products, potentially streamlining operations and ensuring consistent supply. However, it also presents a risk if any of these suppliers face disruptions. The shipment data reveals a stable relationship with Indian suppliers, as evidenced by the consistent import volumes over the years.

2Supply Chain Resilience

Genesis Pharmaceuticals Limited's supply chain resilience is influenced by its reliance on a select group of Indian suppliers. The company's import data indicates a stable relationship with these suppliers, with consistent import volumes over the years.

However, the limited number of suppliers may pose risks in the event of supply chain disruptions. The company's focus on finished pharmaceutical formulations imported from India suggests a reliance on specific shipping routes and regulatory compliance standards. To enhance resilience, it would be prudent for Genesis Pharmaceuticals Limited to diversify its supplier base and establish contingency plans for potential disruptions.

Importing Pharmaceuticals into United Kingdom — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Kingdom

1Regulatory Authority & Framework

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) is the primary regulatory body overseeing the importation and distribution of pharmaceutical products. The MHRA ensures that medicines and medical devices meet appropriate standards of safety, quality, and efficacy. (cms.mhra.gov.uk)

Key legislation governing pharmaceutical imports includes the Human Medicines Regulations 2012 (SI 2012/1916), which consolidates and updates previous regulations. This framework outlines the requirements for marketing authorization, importation, and distribution of medicinal products within the UK. (cms.mhra.gov.uk)

2Import Licensing & GMP

Import licensing requirements in the UK are stringent, necessitating that companies like Genesis Pharmaceuticals Limited hold a valid Manufacturer's Authorisation (MIA) issued by the MHRA. This authorization permits the importation and distribution of medicinal products. (cms.mhra.gov.uk)

Good Manufacturing Practice (GMP) certification is also crucial. The MHRA recognizes GMP certificates from the European Union, World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Suppliers from India must ensure their manufacturing facilities are GMP-compliant to meet UK standards. (cms.mhra.gov.uk)

Genesis Pharmaceuticals Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Genesis Pharmaceuticals Limited's focus on importing Bisacodyl and Lorazepam aligns with market demand in the United Kingdom. Bisacodyl, a stimulant laxative, addresses gastrointestinal issues, while Lorazepam, an anxiolytic, is used for anxiety disorders.

The company's strategy to import these specific therapeutic areas suggests a targeted approach to meet prevalent health concerns, ensuring a steady demand for these products in the UK market.

2Sourcing Profile

Genesis Pharmaceuticals Limited's sourcing strategy emphasizes the importation of generic drugs, particularly in the gastrointestinal and central nervous system therapeutic areas. The company's focus on finished pharmaceutical formulations imported from India indicates a preference for suppliers that can provide high-quality products meeting UK regulatory standards.

India's established pharmaceutical manufacturing sector, with its adherence to international GMP standards, positions it as a key supplier for Genesis Pharmaceuticals Limited.

3Market Positioning

Based on its product mix, Genesis Pharmaceuticals Limited serves the wholesale distribution segment of the United Kingdom market. By supplying wholesalers and hospitals nationwide, the company plays a crucial role in ensuring the availability of essential medicines across the country.

Seller's Guide — How to Become a Supplier to Genesis Pharmaceuticals Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Genesis Pharmaceuticals Limited. The company's focus on high-demand products like Bisacodyl and Lorazepam presents avenues for suppliers to offer competitive pricing and reliable quality.

However, potential suppliers must navigate the stringent regulatory requirements of the UK market, including obtaining GMP certification recognized by the MHRA and ensuring compliance with import licensing regulations.

2Requirements & Qualifications

Indian exporters aiming to supply Genesis Pharmaceuticals Limited and the UK market must obtain GMP certification from recognized bodies such as the European Union, WHO, or PIC/S. (cms.mhra.gov.uk)

Additionally, they must comply with the UK's import licensing requirements, including obtaining a valid Manufacturer's Authorisation from the MHRA. (cms.mhra.gov.uk)

3How to Approach

To build a relationship with Genesis Pharmaceuticals Limited, Indian exporters should first ensure compliance with UK regulatory standards, including obtaining the necessary certifications and authorizations. (cms.mhra.gov.uk)

Frequently Asked Questions — Genesis Pharmaceuticals Limited

What products does Genesis Pharmaceuticals Limited import from India?

Genesis Pharmaceuticals Limited imports 2 pharmaceutical products across 2 categories. Top imports: Bisacodyl ($1.1M), Lorazepam ($290.1K).

Who supplies pharmaceuticals to Genesis Pharmaceuticals Limited from India?

Genesis Pharmaceuticals Limited sources from 5 verified Indian suppliers. The primary supplier is Milan Laboratories (india) Private Limited (30.1% of imports, $258.0K).

What is Genesis Pharmaceuticals Limited's total pharmaceutical import value?

Genesis Pharmaceuticals Limited's total pharmaceutical import value from India is $1.4M, based on 54 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Genesis Pharmaceuticals Limited focus on?

Genesis Pharmaceuticals Limited imports across 2 categories. The largest: Gastrointestinal (78.8%), CNS & Psychiatric (21.2%).

Get Full Genesis Pharmaceuticals Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 4 company name variants from customs records. For current shipment-level data, contact TransData Nexus.